vs

Side-by-side financial comparison of KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) and Pathfinder Bancorp, Inc. (PBHC). Click either name above to swap in a different company.

KESTRA MEDICAL TECHNOLOGIES, LTD. is the larger business by last-quarter revenue ($22.6M vs $11.8M, roughly 1.9× Pathfinder Bancorp, Inc.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -145.3%, a 92.4% gap on every dollar of revenue. Pathfinder Bancorp, Inc. produced more free cash flow last quarter ($10.4M vs $-25.6M).

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

KMTS vs PBHC — Head-to-Head

Bigger by revenue
KMTS
KMTS
1.9× larger
KMTS
$22.6M
$11.8M
PBHC
Higher net margin
PBHC
PBHC
92.4% more per $
PBHC
-52.9%
-145.3%
KMTS
More free cash flow
PBHC
PBHC
$36.0M more FCF
PBHC
$10.4M
$-25.6M
KMTS

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
KMTS
KMTS
PBHC
PBHC
Revenue
$22.6M
$11.8M
Net Profit
$-32.8M
$-5.6M
Gross Margin
50.6%
Operating Margin
-140.7%
-81.1%
Net Margin
-145.3%
-52.9%
Revenue YoY
-22.6%
Net Profit YoY
-242.4%
EPS (diluted)
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
KMTS
KMTS
PBHC
PBHC
Q4 25
$22.6M
$11.8M
Q3 25
$19.4M
$13.1M
Q2 25
$9.3M
Q1 25
$12.6M
Q4 24
$15.3M
Q3 24
$13.4M
Q2 24
$10.7M
Q1 24
$11.1M
Net Profit
KMTS
KMTS
PBHC
PBHC
Q4 25
$-32.8M
$-5.6M
Q3 25
$-25.8M
$626.0K
Q2 25
$31.0K
Q1 25
$3.0M
Q4 24
$3.9M
Q3 24
$-4.6M
Q2 24
$2.0M
Q1 24
$2.1M
Gross Margin
KMTS
KMTS
PBHC
PBHC
Q4 25
50.6%
Q3 25
45.7%
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Operating Margin
KMTS
KMTS
PBHC
PBHC
Q4 25
-140.7%
-81.1%
Q3 25
-149.1%
5.1%
Q2 25
0.4%
Q1 25
29.5%
Q4 24
55.4%
Q3 24
-43.1%
Q2 24
23.3%
Q1 24
24.3%
Net Margin
KMTS
KMTS
PBHC
PBHC
Q4 25
-145.3%
-52.9%
Q3 25
-133.3%
4.8%
Q2 25
0.3%
Q1 25
23.6%
Q4 24
37.7%
Q3 24
-34.6%
Q2 24
18.7%
Q1 24
19.0%
EPS (diluted)
KMTS
KMTS
PBHC
PBHC
Q4 25
$-0.64
Q3 25
$-0.50
$0.47
Q2 25
$0.47
Q1 25
Q4 24
Q3 24
$0.41
Q2 24
$0.41
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
KMTS
KMTS
PBHC
PBHC
Cash + ST InvestmentsLiquidity on hand
$175.4M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$164.1M
$122.5M
Total Assets
$246.7M
$1.4B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
KMTS
KMTS
PBHC
PBHC
Q4 25
$175.4M
Q3 25
$201.2M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Total Debt
KMTS
KMTS
PBHC
PBHC
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
KMTS
KMTS
PBHC
PBHC
Q4 25
$164.1M
$122.5M
Q3 25
$184.2M
$126.3M
Q2 25
$124.4M
Q1 25
$124.9M
Q4 24
$121.5M
Q3 24
$120.2M
Q2 24
$123.3M
Q1 24
$121.8M
Total Assets
KMTS
KMTS
PBHC
PBHC
Q4 25
$246.7M
$1.4B
Q3 25
$266.3M
$1.5B
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.4B
Q1 24
$1.5B
Debt / Equity
KMTS
KMTS
PBHC
PBHC
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
KMTS
KMTS
PBHC
PBHC
Operating Cash FlowLast quarter
$-18.3M
$11.7M
Free Cash FlowOCF − Capex
$-25.6M
$10.4M
FCF MarginFCF / Revenue
-113.5%
88.1%
Capex IntensityCapex / Revenue
32.2%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
KMTS
KMTS
PBHC
PBHC
Q4 25
$-18.3M
$11.7M
Q3 25
$-26.3M
$7.0M
Q2 25
$-3.7M
Q1 25
$5.7M
Q4 24
$11.2M
Q3 24
$11.8M
Q2 24
$1.5M
Q1 24
$504.0K
Free Cash Flow
KMTS
KMTS
PBHC
PBHC
Q4 25
$-25.6M
$10.4M
Q3 25
$-34.4M
$6.9M
Q2 25
$-4.0M
Q1 25
$5.1M
Q4 24
$9.1M
Q3 24
$11.3M
Q2 24
$637.0K
Q1 24
$274.0K
FCF Margin
KMTS
KMTS
PBHC
PBHC
Q4 25
-113.5%
88.1%
Q3 25
-177.8%
52.8%
Q2 25
-42.6%
Q1 25
40.1%
Q4 24
59.9%
Q3 24
84.3%
Q2 24
6.0%
Q1 24
2.5%
Capex Intensity
KMTS
KMTS
PBHC
PBHC
Q4 25
32.2%
10.7%
Q3 25
42.2%
1.0%
Q2 25
2.4%
Q1 25
5.1%
Q4 24
13.5%
Q3 24
3.8%
Q2 24
8.2%
Q1 24
2.1%
Cash Conversion
KMTS
KMTS
PBHC
PBHC
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

KMTS
KMTS

Segment breakdown not available.

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

Related Comparisons